Search Results - "Marty, Francisco M"
-
1
New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19
Published in Antimicrobial agents and chemotherapy (16-12-2020)“…Remdesivir was recently approved by the Food and Drug Administration for the treatment of hospitalized patients with coronavirus disease 2019 (COVID-19)…”
Get full text
Journal Article -
2
A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
Published in Clinical infectious diseases (10-04-2020)“…Abstract Background In a phase 3 trial, letermovir reduced clinically significant cytomegalovirus infections (CS-CMVi) and all-cause mortality at week 24…”
Get full text
Journal Article -
3
A Breath Fungal Secondary Metabolite Signature to Diagnose Invasive Aspergillosis
Published in Clinical infectious diseases (15-12-2014)“…Background. Invasive aspergillosis (IA) remains a leading cause of mortality in immunocompromised patients, in part due to the difficulty of diagnosing this…”
Get full text
Journal Article -
4
Diagnostic Performance of the (1→3)-β-d-Glucan Assay for Invasive Fungal Disease
Published in Clinical infectious diseases (01-12-2009)“…Background.Diagnosis of invasive fungal disease (IFD) is challenging, and it remains a significant cause of morbidity and mortality in immunocompromised…”
Get full text
Journal Article -
5
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients
Published in Blood (06-11-2014)“…Recombinant herpes zoster (HZ) vaccines may be an alternative to the live-attenuated HZ vaccine for immunocompromised individuals. This was a phase 1/2,…”
Get full text
Journal Article -
6
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients
Published in Clinical infectious diseases (31-12-2020)“…Abstract Background Hematopoietic-cell transplant (HCT) recipients are at risk for severe respiratory syncytial virus (RSV) infection. We evaluated the RSV…”
Get full text
Journal Article -
7
Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation
Published in Blood advances (28-08-2018)“…Patients treated with allogeneic hematopoietic cell transplantation (HCT) are at risk of cytomegalovirus (CMV) reactivation and disease, which results in…”
Get full text
Journal Article -
8
Molecular Methods To Improve Diagnosis and Identification of Mucormycosis
Published in Journal of Clinical Microbiology (01-06-2011)“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
9
Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia
Published in PloS one (10-11-2015)“…Invasive fungal disease (IFD) causes significant morbidity and mortality in hematologic malignancy patients with high-risk febrile neutropenia (FN). These…”
Get full text
Journal Article -
10
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
Published in The Lancet infectious diseases (01-04-2011)“…Summary Background Available drugs against cytomegalovirus have adverse effects that compromise their prophylactic use in recipients of allogeneic stem-cell…”
Get full text
Journal Article -
11
Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial
Published in The lancet respiratory medicine (01-02-2017)“…Summary Background Neuraminidase inhibitors are effective for the treatment of acute uncomplicated influenza. However, there is an unmet need for intravenous…”
Get full text
Journal Article -
12
Breakthrough Zygomycosis after Voriconazole Treatment in Recipients of Hematopoietic Stem-Cell Transplants
Published in The New England journal of medicine (26-02-2004)“…To the Editor: The Food and Drug Administration (FDA) approved voriconazole for the treatment of invasive aspergillosis partly on the basis of data published…”
Get full text
Journal Article -
13
Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation
Published in Clinical infectious diseases (16-08-2019)“…Abstract There were no cases of tuberculosis in a cohort of 2531 patients who underwent hematopoietic cell transplantation from 2010 to 2015 after 7323…”
Get full text
Journal Article -
14
The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana‐Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline
Published in The oncologist (Dayton, Ohio) (01-03-2017)“…Background Osteoradionecrosis of the jaw (ORN) is an infrequent yet potentially devastating complication of radiation therapy to the head and neck region…”
Get full text
Journal Article -
15
Isavuconazole Treatment of a Patient with Disseminated Mucormycosis
Published in Journal of Clinical Microbiology (01-03-2014)“…Classifications Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
16
Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis
Published in Journal of Clinical Microbiology (01-04-2010)“…Prognostic features of serum galactomannan (GM) remain poorly defined in patients with GM-positive invasive aspergillosis (GPA). We identified 93 patients with…”
Get full text
Journal Article -
17
Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders
Published in Clinical infectious diseases (01-07-2006)“…Background. Alemtuzumab is an emerging therapy for refractory lymphoproliferative disorders. The associated long-term risks of infection remain poorly defined…”
Get full text
Journal Article -
18
Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis, 2001 to 2009
Published in Antimicrobial Agents and Chemotherapy (01-11-2011)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
19
How to Obtain a Nasopharyngeal Swab Specimen
Published in The New England journal of medicine (28-05-2020)“…Collecting specimens from the surface of the respiratory mucosa with nasopharyngeal swabs is a procedure used to diagnose Covid-19 as well as other respiratory…”
Get full text
Journal Article -
20
Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation
Published in Clinical infectious diseases (01-08-2017)“…Viral infections have been reported with dasatinib use, but its cytomegalovirus risk after hematopoietic-cell transplantation (HCT) is not known. We found that…”
Get full text
Journal Article